In women undergoing IUI, low-dose cetrorelix increased pregnancy rates versus hMG only (21.7% versus 8.7%, p < 0.05).
In plain wordsIn women undergoing IUI, low-dose cetrorelix increased pregnancy rates compared with hMG only.
- Peptide
- Cetrorelix
- Outcome
- IncreasePregnancy rate
- Study
n: not reported in source
- Comparator
- hMG only
- Outcome group
- Sex hormones and fertility · Reproductive and sexual health
- Studied dose
- half of the conventional doseAs given in this study (human).
Measurements
- Pregnancy rate
- 21.7%
- cetrorelix
- Pregnancy rate
- 8.7%
- hMG only
Source sentences
Patients adopting GnRH antagonist at low dose had a pregnancy rate (21.7%) that was significantly higher (p < 0.05) in comparison to women receiving hMG only (8.7%).
2 context sentences(design, population, supporting numbers)
Patients started COS with human menopausal gonadotropin (hMG) on day three of the menstrual cycle.
Cetrorelix was started when at least one follicle of ≥14 mm, was detected at the ultrasound scan, according to the flexible multiple daily dose protocol, and continued until the trigger day with recombinant hCG.